|
|
ASH 2011: Dr. Paiva - High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
Bruno Paiva, MD
Hospital Universitario de Salamanca
Salamanca, Spain
|
|
|